Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intradermal Influenza Vaccine vs Intramuscular Vaxigrip in Adults 50–59 Years
2008-001219-39Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jun 2008
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised trial of Fluzone Intradermal in seasonal influenza (2 arms), sponsored by Sanofi. Primary endpoint: Hemagglutinin inhibition (HI) antibody titers at Day 21. Started Jun 2008; status: completed.
02
Drugs
Fluzone Intradermal
03
Conditions
seasonal influenza
Beyond the preview
Go deeper on 2008-001219-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001219-39.